Table 4.
Two-way ANOVA of the data shown in Figure 5 (nor-BNI and JDTic)
| Row | Figure | Experiment | n | Variable 1 | Variable 2 | Interaction | Subject matching |
|---|---|---|---|---|---|---|---|
| 1 | 5A | Rats CFA | 5 | Time (CFA) | Side | p < 0.0001 | p < 0.0001 |
| p < 0.0001 | p = 0.092 | F(7,56) = 5.7 | F(8,56) = 16.59 | ||||
| F(7,56) = 10.56 | F(1,8) = 4.23 | ||||||
| 2 | 5B | Rats CFA, nor-BNI 1.3 nmol (12 h) | 5 | Time (nor-BNI) | Side | p = 0.95 | p < 0.0001 |
| p < 0.0001 | p = 0.16 | F(4,32) = 0.18 | F(8,32) = 7.26 | ||||
| F(4,32) = 14.66 | F(1,8) = 2.42 | ||||||
| 3 | 5C | Saline | 8 | Time (saline) | Side | p = 0.96 | p < 0.0001 |
| p = 0.46 | p = 0.42 | F(7,98) = 0.26 | F(14,98) = 3.82 | ||||
| F(7,98) = 0.96 | F(1,14) = 0.69 | ||||||
| 4 | 5D | Saline (nor-BNI) | 8 | Time (nor-BNI) | Side | p = 0.37 | p < 0.0001 |
| p = 0.073 | p = 0.88 | F(4,56) = 1.1 | F(14,56) = 4.42 | ||||
| F(4,56) = 2.27 | F(1,14) = 0.025 | ||||||
| 5 | 5E | Mice CFA / saline | 6/6 | Time (CFA) | CFA | p < 0.0001 | p = 0.011 |
| p < 0.0001 | p = 0.021 | F(6,60) = 11.2 | F(10,60) = 2.60 | ||||
| F(6,60) = 15.09 | F(1,10) = 7.48 | ||||||
| 6 | 5F | Mice CFA / saline, JDTic | 6/6 | Time (JDTic) | CFA | p < 0.0001 | p < 0.0001 |
| p < 0.0001 | p = 0.0001 | F(4,40) = 15.3 | F(10,40) = 5.67 | ||||
| F(4,40) = 16.08 | F(1,10) = 36.03 |
Each panel in Figure 5 (indicated in the second column) was analyzed independently by two-way ANOVA. In the fourth column, n is the number of animals in the experiment. In the fifth and sixth columns, the variable is identified first: “time” refers to the time after the injection of the compound in parentheses; “side” is ipsilateral versus contralateral paw, and “CFA” refers to CFA versus saline. Subscript numbers in the F ratio are the degrees of freedom and the residual.